Xconomy’s Digital Events →
Chris Garabedian, CEO of Sarepta Therapeutics
Sponsored · Whitepaper
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.